{"id":"https://openalex.org/W2886075436","doi":"https://doi.org/10.1158/1538-7445.am2018-2823","title":"Abstract 2823: DNA methyltransferase inhibitors sensitize NSCLC cells to PARP inhibitors by induction of a double strand break repair defect","display_name":"Abstract 2823: DNA methyltransferase inhibitors sensitize NSCLC cells to PARP inhibitors by induction of a double strand break repair defect","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2886075436","doi":"https://doi.org/10.1158/1538-7445.am2018-2823","mag":"2886075436"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-2823","doi":"https://doi.org/10.1158/1538-7445.am2018-2823","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2823","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067311031","display_name":"Rachel Abbotts","orcid":"https://orcid.org/0000-0001-8664-8278","observed_orcids":["https://orcid.org/0000-0001-8664-8278"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Abbotts","raw_affiliation_strings":["1University of Maryland, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Maryland, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059640571","display_name":"Michael J. Topper","orcid":"https://orcid.org/0000-0002-2778-4920","observed_orcids":["https://orcid.org/0000-0002-2778-4920"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Topper","raw_affiliation_strings":["2Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113505405","display_name":"Daniel Fontaine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Fontaine","raw_affiliation_strings":["1University of Maryland, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Maryland, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058833122","display_name":"Christopher Biondi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Biondi","raw_affiliation_strings":["1University of Maryland, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Maryland, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110571812","display_name":"Eun Yong Choi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eun Yong Choi","raw_affiliation_strings":["1University of Maryland, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Maryland, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062792789","display_name":"Rena G. Lapidus","orcid":"https://orcid.org/0000-0002-4422-743X","observed_orcids":["https://orcid.org/0000-0002-4422-743X"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rena Lapidus","raw_affiliation_strings":["1University of Maryland, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Maryland, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058612163","display_name":"Stephen B. Baylin","orcid":"https://orcid.org/0000-0003-3697-3798","observed_orcids":["https://orcid.org/0000-0003-3697-3798"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Baylin","raw_affiliation_strings":["2Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045398774","display_name":"Feyruz Virgilia Rassool","orcid":"https://orcid.org/0000-0001-6252-7439","observed_orcids":["https://orcid.org/0000-0001-6252-7439"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feyruz Rassool","raw_affiliation_strings":["1University of Maryland, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Maryland, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"2823","last_page":"2823"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9079999923706055},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.843999981880188},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9829999804496765},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8550000190734863},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.7829999923706055},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.921999990940094},{"id":"https://openalex.org/keywords/parp-trapping","display_name":"PARP trapping","score":0.6399999856948853},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.8410000205039978},{"id":"https://openalex.org/keywords/fancd2","display_name":"FANCD2","score":0.7570000290870667},{"id":"https://openalex.org/keywords/ku80","display_name":"Ku80","score":0.9729999899864197},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.5659999847412109},{"id":"https://openalex.org/keywords/epigenetic-reprogramming","display_name":"epigenetic reprogramming","score":0.6830000281333923},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6990000009536743},{"id":"https://openalex.org/keywords/a549-xenograft","display_name":"A549 xenograft","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ionizing-radiation","display_name":"ionizing radiation","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.6683027148246765},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6326346397399902},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.6001574397087097},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5459545850753784},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5345033407211304},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.5202490091323853},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5079556107521057},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44545015692710876},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4327152371406555},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43111541867256165},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.42830953001976013},{"id":"https://openalex.org/C175211621","wikidata":"https://www.wikidata.org/wiki/Q14907998","display_name":"DNMT1","level":5,"score":0.41685670614242554},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.415263295173645},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.3593364953994751},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3255837857723236},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.27798357605934143},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18461644649505615},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1449691653251648},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07068398594856262},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-2823","doi":"https://doi.org/10.1158/1538-7445.am2018-2823","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2823","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2740986751","https://openalex.org/W2979501499","https://openalex.org/W2485585585","https://openalex.org/W2889230329","https://openalex.org/W2772948229","https://openalex.org/W2530874742","https://openalex.org/W3133587423","https://openalex.org/W4282976488","https://openalex.org/W2178808625","https://openalex.org/W2024795485"],"abstract_inverted_index":{"Abstract":[0],"Non-small":[1],"cell":[2,171,257,307],"lung":[3],"cancer":[4,34,107,242],"(NSCLC)":[5],"is":[6,60,186,322],"the":[7,14,46,153,165,241,274,282,288,393,451],"leading":[8],"cause":[9],"of":[10,51,65,69,160,183,190,270,281,327,355,440,450],"cancer-related":[11],"death":[12],"in":[13,25,33,41,45,101,162,169,199,236,240,273,304,336,365,390,392],"US.":[15],"Poly":[16],"(ADP-ribose)":[17],"polymerase":[18],"inhibitors":[19,431,437],"(PARPi)":[20],"show":[21,251],"efficacy":[22],"as":[23,77],"radiosensitizers":[24],"NSCLC,":[26],"but":[27],"arguably":[28],"have":[29,228],"gained":[30],"greater":[31],"importance":[32],"therapeutics":[35],"by":[36,148,173,252,299,352,377,438],"exhibiting":[37],"synthetic":[38],"lethality":[39],"(SL)":[40],"tumors":[42],"with":[43,72,92,129,164,264,315,324],"defects":[44],"homologous":[47],"recombination":[48],"(HR)":[49],"pathway":[50],"double":[52,142,442],"strand":[53,143,443],"break":[54,444],"repair":[55,276,445],"(DSBR).":[56],"Mechanistically,":[57],"PARPi":[58,99,378],"cytotoxicity":[59,100,159,185],"partially":[61],"mediated":[62],"through":[63],"trapping":[64,134],"PARP1":[66],"at":[67,135],"sites":[68],"DNA":[70,94,191,245,275,429],"damage,":[71],"next":[73],"generation":[74],"PARPis":[75],"such":[76],"talazoparib":[78],"(Tal)":[79],"being":[80],"potent":[81],"PARP":[82,133,436],"trappers.":[83],"Our":[84],"group":[85],"has":[86],"previously":[87,229],"demonstrated":[88],"that":[89,113,231,255,362,371,402],"combining":[90],"Tal":[91,161],"a":[93,149,316,368,398,441],"methyltransferase":[95,430],"inhibitor":[96],"(DNMTi)":[97],"enhances":[98],"acute":[102],"myeloid":[103],"leukaemia":[104],"and":[105,177,213,226,268,287,301,309,332,379],"breast":[106],"models.":[108],"DNMTis":[109,131],"are":[110,388],"cytosine":[111],"analogs":[112],"become":[114],"incorporated":[115],"into":[116,140,407],"replicating":[117],"DNA,":[118],"where":[119,207],"they":[120],"covalently":[121],"bind":[122],"their":[123],"target":[124],"enzyme":[125],"DNMT1.":[126],"When":[127],"combined":[128],"PARPi,":[130],"enhance":[132],"damage":[136,192,246],"sites,":[137],"which":[138],"collapse":[139],"cytotoxic":[141],"breaks":[144],"(DSB)":[145],"when":[146],"encountered":[147],"replication":[150],"fork.":[151],"In":[152,313],"current":[154],"study,":[155],"we":[156,250],"demonstrate":[157],"synergistic":[158],"combination":[163,174,396],"DNMTi":[166,234],"5-azacytidine":[167],"(Aza)":[168],"NSCLC":[170,256,306,366,433],"lines":[172,258,308],"index":[175],"analyses":[176],"colony":[178],"forming":[179],"assays.":[180],"Further":[181],"potentiation":[182],"Tal+Aza":[184,221],"observed":[187],"following":[188,330],"induction":[189,439],"via":[193],"IR.":[194,384],"These":[195,295,359],"results":[196,235,296,360],"were":[197,297],"substantiated":[198],"an":[200,337],"A549":[201],"xenograft":[202,310],"model":[203],"(n=8":[204],"per":[205],"group)":[206],"Tal+Aza+IR":[208],"significantly":[209],"reduced":[210,325,333],"tumor":[211,311],"volume":[212],"increased":[214,342],"survival":[215],"compared":[216],"to":[217,344,383,435],"vehicle":[218],"(p<0.001)":[219],"or":[220],"without":[222],"IR":[223,345],"(p<0.05).":[224],"We":[225],"others":[227],"reported":[230],"low":[232],"dose":[233],"stable":[237],"transcriptional":[238],"changes":[239],"epigenome,":[243],"including":[244,278],"response":[247],"pathways.":[248],"Here,":[249],"microarray":[253],"analysis":[254],"(A549,":[259],"H23,":[260],"H1299,":[261],"H460)":[262],"treated":[263],"Aza":[265,320,347,363],"exhibit":[266],"up-":[267],"downregulation":[269],"multiple":[271],"genes":[272],"reactome,":[277],"decreased":[279,353],"expression":[280,354],"key":[283],"HR-related":[284],"gene":[285,293],"FANCD2,":[286],"non-homologous":[289],"end":[290],"joining":[291],"(NHEJ)":[292],"Ku80.":[294,358],"validated":[298],"mRNA":[300],"protein":[302],"quantification":[303],"Aza-treated":[305],"samples.":[312],"keeping":[314],"FANCD2-associated":[317],"HR":[318,334,339],"defect,":[319],"exposure":[321],"associated":[323],"accumulation":[326],"RAD51":[328],"foci":[329],"IR,":[331],"activity":[335],"extrachromosomal":[338],"assay.":[340],"Additionally,":[341],"sensitivity":[343],"post":[346],"treatment":[348,364],"can":[349,372,380],"be":[350,373,404],"explained":[351],"NHEJ":[356],"factor":[357],"indicate":[361],"induces":[367],"DSBR":[369],"deficiency":[370],"targeted":[374],"for":[375,454],"SL":[376],"further":[381],"sensitize":[382,432],"Given":[385],"these":[386],"agents":[387],"currently":[389],"use":[391],"clinic,":[394],"this":[395],"offers":[397],"promising":[399],"therapeutic":[400],"strategy":[401],"could":[403],"rapidly":[405],"translated":[406],"clinical":[408],"practice.":[409],"Citation":[410],"Format:":[411],"Rachel":[412],"Abbotts,":[413],"Michael":[414],"Topper,":[415],"Daniel":[416],"Fontaine,":[417],"Christopher":[418],"Biondi,":[419],"Eun":[420],"Yong":[421],"Choi,":[422],"Rena":[423],"Lapidus,":[424],"Stephen":[425],"Baylin,":[426],"Feyruz":[427],"Rassool.":[428],"cells":[434],"defect":[446],"[abstract].":[447],"In:":[448],"Proceedings":[449],"American":[452],"Association":[453],"Cancer":[455,468],"Research":[456],"Annual":[457],"Meeting":[458],"2018;":[459],"2018":[460],"Apr":[461],"14-18;":[462],"Chicago,":[463],"IL.":[464],"Philadelphia":[465],"(PA):":[466],"AACR;":[467],"Res":[469],"2018;78(13":[470],"Suppl):Abstract":[471],"nr":[472],"2823.":[473]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-08-22T00:00:00"}